ImmPACT Bio USA: Funding, Investors & Team (Oct 2026)
ImmPACT Bio USA Inc. is a cell therapy company aiming to develop potent and selective engineered T-cells for the treatment of solid tumors. The Company's technology enables targeting loss-of-gene features of solid tumor cells, sparing normal, healthy tissues.
ImmPACT Bio USA has raised $18.0M across 1 funding round on record, the most recent an undisclosed round of $18.0M announced in Aug 2020.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
ImmPACT Bio USA Company Profile and Key Stats
Latest funding round on record: Aug 2020.
ImmPACT Bio USA Funding Rounds
ImmPACT Bio USA Founders and Leadership Team
No contact details are on record for this team yet.
ImmPACT Bio USA Funding Compared to Other Biotechnology Startups
ImmPACT Bio USA's latest round of $18.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like ImmPACT Bio USA in Biotechnology and Camarillo
Companies Similar to ImmPACT Bio USA
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
ImmPACT Bio USA Funding FAQs
What does ImmPACT Bio USA do?
ImmPACT Bio USA Inc. is a cell therapy company aiming to develop potent and selective engineered T-cells for the treatment of solid tumors. The Company's technology enables targeting loss-of-gene features of solid tumor cells, sparing normal, healthy tissues.
How much funding has ImmPACT Bio USA raised?
ImmPACT Bio USA has raised $18.0M across 1 round on record. The most recent is an undisclosed round of $18.0M announced in Aug 2020.
When did ImmPACT Bio USA last raise funding?
ImmPACT Bio USA's most recent funding round on record is an undisclosed round of $18.0M, announced in Aug 2020.
Who is the CEO of ImmPACT Bio USA?
Rick Kendall is listed as CEO at ImmPACT Bio USA.
Where is ImmPACT Bio USA headquartered?
ImmPACT Bio USA is based in Camarillo, California, United States.
How many employees does ImmPACT Bio USA have?
ImmPACT Bio USA is in the 1-10 employee band.
How does ImmPACT Bio USA's funding compare to other Biotechnology startups?
ImmPACT Bio USA's latest round of $18.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's ImmPACT Bio USA Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for ImmPACT Bio USA is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.